EichorEICHOR
Condition: Carcinoma Of The Breast Synced from ClinicalTrials.gov · August 07, 2026

Recruiting studies: Carcinoma Of The Breast

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
Phase N/A · 4 location(s) · University of Southern California · NCT06336928Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies
Phase 1 · 10 location(s) · Circle Pharma · NCT06577987The Impact of Inhalation vs Total Intravenous Anesthesia on the Immune Status and Mortality in Patients Undergoing Breas
NA · 1 location(s) · Moscow Clinical Scientific Center · NCT04800393A Study of GC203 TIL in Advanced Malignant Solid Tumors
Phase 1 · 1 location(s) · Shanghai Juncell Therapeutics · NCT06375187Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery
Phase 2/Phase 3 · 1 location(s) · M.D. Anderson Cancer Center · NCT05766891Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metas
Phase 2 · 30 location(s) · National Cancer Institute (NCI) · NCT03606967Investigating Paclitaxel Toxicity in Breast Cancer: the Roles of Physical Activity and Body Composition.
Phase N/A · 2 location(s) · Universitair Ziekenhuis Brussel · NCT06387901X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma
Phase 1 · 4 location(s) · Immunolight, LLC · NCT04389281Breast Density Impact on Mammographic Screening for Breast Cancer Diagnosis
Phase N/A · 1 location(s) · Azienda Sanitaria Locale CN2 Alba-Bra · NCT07415499A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breas
NA · 1 location(s) · Fudan University · NCT06856200Sustainable and Efficient Platform Trial of New Therapeutic Development for Early Breast Cancer
Phase 2 · 1 location(s) · Nagoya City University · NCT06535893PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Dam
Phase 2 · 6 location(s) · Institute of Cancer Research, United Kingdom · NCT03740893Adjuvant Chemoradiation and Biomarkers of Response in High-risk Breast Cancer
Phase 2/Phase 3 · 1 location(s) · University of Virginia · NCT05288777Cognitive Rehabilitation Following Breast Cancer Treatment
NA · 1 location(s) · University of Missouri-Columbia · NCT06545045Collecting Patient-Reported Experiences With Radiation Dermatitis in Breast Cancer Patients Undergoing Radiotherapy
Phase N/A · 1 location(s) · Mayo Clinic · NCT06953245Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormon
Phase N/A · 24 location(s) · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · NCT06805812Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ
Phase 3 · 9 location(s) · Uppsala University · NCT04722692A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection
NA · 4 location(s) · Umbria Bioengineering Technologies · NCT05300464Safety of Elacestrant in ER+/HER2- and ESR1 Mutations MBC
Phase N/A · 1 location(s) · SciClone Pharmaceuticals · NCT06544577Photoacoustic Imaging for Characterizing Breast Masses and Breast Tumor Response to Neoadjuvant Chemotherapy
Phase N/A · 1 location(s) · Sunnybrook Health Sciences Centre · NCT04428528CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
Phase 1 · 7 location(s) · University of Texas Southwestern Medical Center · NCT05029999A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Ex
Phase 1/Phase 2 · 5 location(s) · Kidney Cancer Research Bureau · NCT07292168Using a Blood Test to Monitor Metastatic Breast Cancer Treatment
Phase N/A · 2 location(s) · Dr. Christopher Mueller · NCT05804578Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Bre
Phase 4 · 52 location(s) · Institut fuer Frauengesundheit · NCT05452213Predicting BReast cAncer Response to neoadjuVant Therapy by ctDNA Assessment
Phase N/A · 3 location(s) · Gene Solutions · NCT06087120Tumour Cell Response to Acute Aerobic Exercise in Breast Cancer Survivors: Modulatory Effects of Exercise Type and Inten
NA · 1 location(s) · Riga Stradins University · NCT07439458FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endo
Phase 2 · 2 location(s) · Yale University · NCT06917313Triplex Checkpoint Inhibitors Therapy for Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT05187338SBRT, Chemotherapy, and AK112 Neoadjuvant Therapy for Luminal-type Breast Cancer
Phase 2 · 1 location(s) · Hubei Cancer Hospital · NCT06402435Al18F-HER2-BCH PET in Breast Patients Treated With ADC Therapy
NA · 1 location(s) · Peking University Cancer Hospital & Institute · NCT06909604
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.